Medical Research
(H43)
IRS Verified
DX Registered
990 on File
CONQUERING CONGENITAL HEART DISEASE
Financial strength (30%)
66/100
Reliability (20%)
50/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$292K
Total Revenue
$334K
Total Expenses
$18K
Net Assets
6
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.5%
Fundraising Efficiency
N/A
Operating Reserve
0.64x
Liability-to-Asset
16.9%
Revenue Diversification
85.9%
Executive Compensation
$86K
Compared with Peers
FY 2023
Compared with 1,004 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.5% | 86.3% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
13.5% | 10.6% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
0.6 mo | 13.1 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
16.9% | 0.3% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
85.9% | 95.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-54.8% | 4.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-47.0% | 12.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-14.4% | -0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $292K | $334K | $18K | 86.5% | 6 |
| 2022 | $645K | $630K | $60K | 75.3% | 9 |
| 2021 | $582K | $697K | N/A | — | 12 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.